Literature DB >> 8564219

Renal effects of infusion of rilmenidine and guanabenz in conscious dogs: contribution of peripheral and central nervous system alpha 2-adrenoceptors.

R G Evans1, W P Anderson.   

Abstract

1. We tested the renal effects of the alpha 2-adrenoceptor agonists, rilmenidine and guanabenz and the antagonists, 2-methoxyidazoxan and idazoxan, in conscious dogs. Our aim was to test the hypothesis that putative imidazoline (I) receptors influence renal function. We reasoned that since rilmenidine and guanabenz are selective for I1- and I2-binding sites respectively, an influence of one of these receptive sites on renal function would be reflected in qualitative differences between the effects of these agents. Moreover, effects mediated by putative I-receptors should be relatively resistant to antagonism by the selective alpha 2-adrenoceptor antagonist, 2-methoxyidazoxan. Since the effects of these drugs on renal function could be mediated in the central nervous system or periphery, the dogs were studied under both normal and ganglion-blocked conditions. 2. In dogs with intact autonomic reflexes, 2-methoxyidazoxan (15 micrograms kg-1 plus 0.6 micrograms kg-1 min-1) produced effects consistent with a generalized increase in sympathetic drive, including increases in mean arterial pressure and plasma renin activity, and a reduction in sodium excretion. In ganglion-blocked dogs, 2-methoxyidazoxan reduced sodium excretion but had no discernible effect on systemic or renal haemodynamics. We conclude that an alpha 2-adrenoceptor-mediated mechanism in the central nervous system tonically inhibits sympathetic drive in the conscious dog. 3. In ganglion-blocked dogs idazoxan (3-300 micrograms kg-1) dose-dependently increased arterial pressure. This was not abolished by concomitant administration of 2-methoxyidazoxan (0.3-30 micrograms kg-1). The pressor effect of idazoxan is therefore probably mediated by an agonist action at alpha 1-adrenoceptors. 4. The effects of infusions of rilmenidine (0.1-1.0 mg kg-1) and guanabenz (10-100 micrograms kg-1) were indistinguishable. They comprised dose-dependent increases in mean arterial pressure, urine excretion, and glomerular filtration rate (the latter in ganglion blocked dogs only), and dose-dependent reductions in heart rate, renal blood flow and sodium excretion (only in dogs with intact autonomic reflexes). All of these effects were antagonized by 2-methoxyidazoxan. 5. We conclude that the renal effects of rilmenidine and guanabenz infusions in conscious dogs are predominantly, if not completely, attributable to activation of alpha 2-adrenoceptors. Our results do not support the hypothesis that putative I-receptors contribute towards the renal effects of these agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8564219      PMCID: PMC1908919          DOI: 10.1111/j.1476-5381.1995.tb16373.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Studies on the centrally mediated hypotensive activity of guanabenz.

Authors:  T Baum; A T Shropshire
Journal:  Eur J Pharmacol       Date:  1976-05       Impact factor: 4.432

2.  Water diuresis from clonidine (catapres).

Authors:  S G Chrysanthakopoulos; A R Lavender
Journal:  Proc Soc Exp Biol Med       Date:  1975-10

3.  Synergistic effect of modest volume expansion on the diuretic and natriuretic action of guanabenz.

Authors:  J W Strandhoy; M Morris; B D Steg; V M Buckalew
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

4.  Characterization and visualization of clonidine-sensitive imidazole sites in rat kidney which recognize clonidine-displacing substance.

Authors:  P Ernsberger; G Feinland; M P Meeley; D J Reis
Journal:  Am J Hypertens       Date:  1990-02       Impact factor: 2.689

5.  Atrial natriuretic peptide infusion causes vasoconstriction after autonomic blockade in conscious dogs.

Authors:  R L Woods; W P Anderson
Journal:  Am J Physiol       Date:  1990-10

6.  Characterization of imidazoline-guanidinium receptive sites in renal medulla from human kidney.

Authors:  V Lachaud; I Limon; F Tesson; I Coupry; A Parini
Journal:  Am J Hypertens       Date:  1992-04       Impact factor: 2.689

7.  Effects of anesthesia on cardiac and renal sympathetic nerve activities and plasma catecholamines.

Authors:  K Matsukawa; I Ninomiya; N Nishiura
Journal:  Am J Physiol       Date:  1993-10

8.  Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.

Authors:  R E Gomez; P Ernsberger; G Feinland; D J Reis
Journal:  Eur J Pharmacol       Date:  1991-03-26       Impact factor: 4.432

9.  Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes.

Authors:  G J Molderings; D Moura; K Fink; H Bönisch; M Göthert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-07       Impact factor: 3.000

10.  Guanabenz, guanochlor, guanoxan and idazoxan bind with high affinity to non-adrenergic sites in pig kidney membranes.

Authors:  P Vigne; M Lazdunski; C Frelin
Journal:  Eur J Pharmacol       Date:  1989-01-31       Impact factor: 4.432

View more
  2 in total

Review 1.  The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease.

Authors:  P Ernsberger; J E Friedman; R J Koletsky
Journal:  J Hypertens Suppl       Date:  1997-01

2.  Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.

Authors:  F Tomoda; R A Lew; A I Smith; A C Madden; R G Evans
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.